Literature DB >> 33047340

A controlled trial of dissemination and implementation of a cardiovascular risk reduction strategy in small primary care practices.

Samuel Cykert1,2, Thomas C Keyserling2,3, Michael Pignone4, Darren DeWalt1,2, Bryan J Weiner5, Justin G Trogdon6, Thomas Wroth7, Jacqueline Halladay1,8, Monique Mackey9, Jason Fine10, Jung In Kim11,12, Crystal Cene1,2.   

Abstract

OBJECTIVE: To assess the effect of dissemination and implementation of an intervention consisting of practice facilitation and a risk-stratified, population management dashboard on cardiovascular risk reduction for patients at high risk in small, primary care practices. STUDY
SETTING: A total of 219 small primary care practices (≤10 clinicians per site) across North Carolina with primary data collection from electronic health records (EHRs) from the fourth quarter of 2015 through the second quarter of 2018. STUDY
DESIGN: We performed a stepped-wedge, stratified, cluster randomized trial of a one-year intervention consisting of practice facilitation utilizing quality improvement techniques coupled with a cardiovascular dashboard that included lists of risk-stratified adults, aged 40-79 years and their unmet treatment opportunities. The primary outcome was change in 10-Year ASCVD Risk score among all patients with a baseline score ≥10 percent from baseline to 3 months postintervention. DATA COLLECTION/ EXTRACTION
METHODS: Data extracts were securely transferred from practices on a nightly basis from their EHR to the research team registry. PRINCIPLE
FINDINGS: ASCVD risk scores were assessed on 437 556 patients and 146 826 had a calculated 10-year risk ≥10 percent. The mean baseline risk was 23.4 percent (SD ± 12.6 percent). Postintervention, the absolute risk reduction was 6.3 percent (95% CI 6.3, 6.4). Models considering calendar time and stepped-wedge controls revealed most of the improvement (4.0 of 6.3 percent) was attributable to the intervention and not secular trends. In multivariate analysis, male gender, age >65 years, low-income (<$40 000), and Black race (P < .001 for all variables) were each associated with greater risk reductions.
CONCLUSION: A risk-stratified, population management dashboard combined with practice facilitation led to substantial reductions of 10-year ASCVD risk for patients at high risk. Similar approaches could lead to effective dissemination and implementation of other new evidence, especially in rural and other under-resourced practices. Registration: ClinicalTrials.Gov 15-0479. © Health Research and Educational Trust.

Entities:  

Keywords:  CVD risk reduction; practice facilitation; primary care; primary prevention; quality improvement; risk stratification; statins

Mesh:

Year:  2020        PMID: 33047340      PMCID: PMC7704467          DOI: 10.1111/1475-6773.13571

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  40 in total

1.  The break-even point: when medical advances are less important than improving the fidelity with which they are delivered.

Authors:  Steven H Woolf; Robert E Johnson
Journal:  Ann Fam Med       Date:  2005 Nov-Dec       Impact factor: 5.166

2.  Practice facilitation to improve diabetes care in primary care: a report from the EPIC randomized clinical trial.

Authors:  W Perry Dickinson; L Miriam Dickinson; Paul A Nutting; Caroline B Emsermann; Brandon Tutt; Benjamin F Crabtree; Lawrence Fisher; Marjie Harbrecht; Allyson Gottsman; David R West
Journal:  Ann Fam Med       Date:  2014 Jan-Feb       Impact factor: 5.166

3.  Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  David M Reboussin; Norrina B Allen; Michael E Griswold; Eliseo Guallar; Yuling Hong; Daniel T Lackland; Edgar Pete R Miller; Tamar Polonsky; Angela M Thompson-Paul; Suma Vupputuri
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

4.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

5.  Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.

Authors:  Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Karina W Davidson; John W Epling; Francisco A R García; Matthew W Gillman; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Michael L LeFevre; Carol M Mangione; William R Phillips; Douglas K Owens; Maureen G Phipps; Michael P Pignone
Journal:  JAMA       Date:  2016-11-15       Impact factor: 56.272

6.  Meaningful Use in Chronic Care: Improved Diabetes Outcomes Using a Primary Care Extension Center Model.

Authors:  Samuel Cykert; Ann Lefebvre; Thomas Bacon; Warren Newton
Journal:  N C Med J       Date:  2016 Nov-Dec

7.  Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.

Authors:  Jordan Fulcher; Rachel O'Connell; Merryn Voysey; Jonathan Emberson; Lisa Blackwell; Borislava Mihaylova; John Simes; Rory Collins; Adrienne Kirby; Helen Colhoun; Eugene Braunwald; John La Rosa; T R Pedersen; Andrew Tonkin; Barry Davis; Peter Sleight; Maria Grazia Franzosi; Colin Baigent; Anthony Keech
Journal:  Lancet       Date:  2015-01-09       Impact factor: 79.321

8.  Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.

Authors:  Louise Bowman; Marion Mafham; Karl Wallendszus; Will Stevens; Georgina Buck; Jill Barton; Kevin Murphy; Theingi Aung; Richard Haynes; Jolyon Cox; Aleksandra Murawska; Allen Young; Michael Lay; Fang Chen; Emily Sammons; Emma Waters; Amanda Adler; Jonathan Bodansky; Andrew Farmer; Roger McPherson; Andrew Neil; David Simpson; Richard Peto; Colin Baigent; Rory Collins; Sarah Parish; Jane Armitage
Journal:  N Engl J Med       Date:  2018-08-26       Impact factor: 91.245

9.  Implementing asthma guidelines using practice facilitation and local learning collaboratives: a randomized controlled trial.

Authors:  James W Mold; Chester Fox; Angela Wisniewski; Paula Darby Lipman; Margot R Krauss; D Robert Harris; Cheryl Aspy; Rachel A Cohen; Kurt Elward; Paul Frame; Barbara P Yawn; Leif I Solberg; René Gonin
Journal:  Ann Fam Med       Date:  2014 May-Jun       Impact factor: 5.166

10.  A real-world stepped wedge cluster randomized trial of practice facilitation to improve cardiovascular care.

Authors:  Clare Liddy; William Hogg; Jatinderpreet Singh; Monica Taljaard; Grant Russell; Catherine Deri Armstrong; Ayub Akbari; Simone Dahrouge; Jeremy M Grimshaw
Journal:  Implement Sci       Date:  2015-10-28       Impact factor: 7.327

View more
  3 in total

1.  A controlled trial of dissemination and implementation of a cardiovascular risk reduction strategy in small primary care practices.

Authors:  Samuel Cykert; Thomas C Keyserling; Michael Pignone; Darren DeWalt; Bryan J Weiner; Justin G Trogdon; Thomas Wroth; Jacqueline Halladay; Monique Mackey; Jason Fine; Jung In Kim; Crystal Cene
Journal:  Health Serv Res       Date:  2020-10-13       Impact factor: 3.402

2.  A Heart Healthy Intervention Improved Tobacco Screening Rates and Cessation Support in Primary Care Practices.

Authors:  Sarah D Kowitt; Adam O Goldstein; Samuel Cykert
Journal:  J Prev (2022)       Date:  2022-03-17

3.  Assessing Preconception Wellness in the Clinical Setting Using Electronic Health Data.

Authors:  Megan Scull Williams; Rachel Peragallo Urrutia; Scott A Davis; Daniel Frayne; Arthur Ollendorff; Melinda Ramage; Sarah Verbiest; Amina White
Journal:  J Womens Health (Larchmt)       Date:  2021-12-17       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.